← Back to headlines

Medicare Drug Price Controls Could Raise Prices Long-Term
New research suggests that Medicare's drug price controls, intended to save taxpayers over $100 billion, could paradoxically lead to higher prices in the long run.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.



